Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 72: 1425-1431, 1992;
8750-7587/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawley, D. E.
Right arrow Articles by Evans, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawley, D. E.
Right arrow Articles by Evans, T. W.

Journal of Applied Physiology, Vol 72, Issue 4 1425-1431, Copyright © 1992 by American Physiological Society

ARTICLES

Endothelin-3 is a potent pulmonary vasodilator in the rat

D. E. Crawley, S. F. Liu, P. J. Barnes and T. W. Evans
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

The properties of endothelin-3 (ET-3) were investigated in isolated pulmonary artery rings and isolated blood-perfused lungs of the rat. ET-3 elicited a concentration-dependent relaxation of pulmonary artery rings, and effect inhibited by the nitric oxide synthesis inhibitor L-NG-monomethyl-L-arginine. At 0.1 microM, the response to ET-3 was biphasic, resulting in a sustained contraction. In the isolated lung, ET-3 caused a dose-dependent increase in pulmonary arterial pressure. In lungs ventilated with 3% oxygen, 10 nM ET-3 completely reversed the resultant hypoxic vasoconstriction (HPV) by 100 +/- 8%, an effect unchanged by either indomethacin (1 microM) or glibenclamide (10 microM). L-NG-monomethyl-L-arginine attenuated both the ET-3 dilation in prostaglandin F2 alpha-constricted lungs and the dose-dependent vasodilation of HPV by acetylcholine. ET-3 (10 nM) showed the response time to peak pulmonary arterial pressure generation by hypoxia, the size of the response being unchanged. These results demonstrate that ET-3 has both vasodilator and constrictor actions in the rat lung and that, like acetylcholine, the former is mediated in part via the release of nitric oxide. ET-3 also has the ability to modulate HPV.


This article has been cited by other articles:


Home page
 ChestHome page
D. Montani, R. Souza, C. Binkert, W. Fischli, G. Simonneau, M. Clozel, and M. Humbert
Endothelin-1/Endothelin-3 Ratio: A Potential Prognostic Factor of Pulmonary Arterial Hypertension
Chest, January 1, 2007; 131(1): 101 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Thomson, P. Kumarathasan, and R. Vincent
Pulmonary Expression of PreproET-1 and PreproET-3 mRNAs Is Altered Reciprocally in Rats After Inhalation of Air Pollutants.
Experimental Biology and Medicine, June 1, 2006; 231(6): 979 - 984.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Shi, P. Cernacek, F. Hu, and R. P. Michel
Endothelin reactivity and receptor profile of pulmonary vessels in postobstructive pulmonary vasculopathy
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2558 - H2564.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online